{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:31:17Z","timestamp":1791228677113,"version":"4.1.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2003,5,1]],"date-time":"2003-05-01T00:00:00Z","timestamp":1051747200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,5,1]],"date-time":"2003-05-01T00:00:00Z","timestamp":1051747200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,5,1]],"date-time":"2003-05-01T00:00:00Z","timestamp":1051747200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2003,5]]},"DOI":"10.1007\/bf02982645","type":"journal-article","created":{"date-parts":[[2008,11,3]],"date-time":"2008-11-03T17:43:21Z","timestamp":1225734201000},"page":"364-370","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Constitutive Activation of Extracellular Signal-Regulated Kinase and p38 Mitogen-Activated Protein Kinase in B-Cell Lymphoproliferative Disorders"],"prefix":"10.1007","volume":"77","author":[{"given":"Toshie","family":"Ogasawara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Yasuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyotaka","family":"Kawauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,5,1]]},"reference":[{"key":"BF02982645_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/35065000","volume":"410","author":"L Chang","year":"2001","unstructured":"Chang L, Karin M. Mammalian MAP kinase signalling cascades.Nature. 2001;410:37\u201340.","journal-title":"Nature."},{"key":"BF02982645_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/sj.leu.2401998","volume":"15","author":"DM O\u2019Gorman","year":"2001","unstructured":"O\u2019Gorman DM, Cotter TG. Molecular signals in anti-apoptotic survival pathways.Leukemia. 2001;15:21\u201334.","journal-title":"Leukemia."},{"key":"BF02982645_CR3","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1182\/blood.V92.6.1859","volume":"92","author":"Y Nagata","year":"1998","unstructured":"Nagata Y, Takahashi N, Davis RJ, Todokoro K. Activation of p38 MAP kinase and JNK but not ERK is required for erythropoietininduced erythroid differentiation.Blood. 1998;92:1859\u20131869.","journal-title":"Blood."},{"key":"BF02982645_CR4","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1182\/blood.V96.3.933","volume":"96","author":"SM Jacobs-Helber","year":"2000","unstructured":"Jacobs-Helber SM, Ryan JJ, Sawyer S. JNK and p38 are activated by erythropoietin (EPO) but are not induced in apoptosis following EPO withdrawal in EPO-dependent HCD57 cells.Blood. 2000;96:933\u2013940.","journal-title":"Blood."},{"key":"BF02982645_CR5","doi-asserted-by":"publisher","first-page":"7779","DOI":"10.1038\/sj.onc.1204984","volume":"20","author":"H Yamaguchi","year":"2001","unstructured":"Yamaguchi H, Wang H-G. The protein kinase PKB\/Akt regulates cell survival and apoptosis by inhibiting Bax conformational change.Oncogene. 2001;20:7779\u20137786.","journal-title":"Oncogene."},{"key":"BF02982645_CR6","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/sj.onc.1202367","volume":"18","author":"R Hoshino","year":"1999","unstructured":"Hoshino R, Chatani Y, Yamori T, et al. Constitutive activation of the 41-\/43-kDa mitogen-activated protein kinase signaling pathway in human tumors.Oncogene. 1999;18:813\u2013822.","journal-title":"Oncogene."},{"key":"BF02982645_CR7","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/BF02982115","volume":"75","author":"K Kawauchi","year":"2002","unstructured":"Kawauchi K, Ogasawara T, Yasuyama M. Activation of extracellular signal-regulated kinase through B-cell antigen receptor in B-cell chronic lymphocytic leukemia.Int J Hematol. 2002;75:508\u2013513.","journal-title":"Int J Hematol."},{"key":"BF02982645_CR8","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1182\/blood.V96.5.1655","volume":"96","author":"CWM Reuter","year":"2000","unstructured":"Reuter CWM, Morgan MA, Bergmann L. Targeting the Ras signaling pathway: a rational, mechanism-based treatment for hematologic malignancies?Blood. 2000;96:1655\u20131669.","journal-title":"Blood."},{"key":"BF02982645_CR9","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1128\/MCB.17.4.1947","volume":"17","author":"AM Whalen","year":"1997","unstructured":"Whalen AM, Galasinski SC, Shapiro PS, Nahreini TS, Ahn NG. Megakaryocytic differentiation induced by constitutive activation of mitogen-activated protein kinase kinase.Mol Cell Biol. 1997;17:1947\u20131958.","journal-title":"Mol Cell Biol."},{"key":"BF02982645_CR10","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1146\/annurev.immunol.17.1.555","volume":"17","author":"T Kurosaki","year":"1999","unstructured":"Kurosaki T. Genetic analysis of B cell antigen receptor signaling.Annu Rev Immunol. 1999;17:555\u2013592.","journal-title":"Annu Rev Immunol."},{"key":"BF02982645_CR11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/S0167-5699(99)01574-1","volume":"21","author":"M. Turner","year":"2000","unstructured":"Turner M., Schweighoffer E, Colucci F, Di Santo JP, Tybulewicz L. Tyrosine kinase SYK: essential functions for immunoreceptor signalling.Immunol Today. 2000;21:148\u2013154.","journal-title":"Immunol Today."},{"key":"BF02982645_CR12","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0065-2776(00)75007-3","volume":"75","author":"RC Hsueh","year":"2000","unstructured":"Hsueh RC, Scheuermann RH. Tyrosine kinase activation in the decision between growth, differentiation, and death responses initiated from the B cell antigen receptor.Adv Immunol. 2000;75:283\u2013310.","journal-title":"Adv Immunol."},{"key":"BF02982645_CR13","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1096\/fj.00-0102rev","volume":"14","author":"MG Wilkinson","year":"2000","unstructured":"Wilkinson MG, Millar JB. Control of the eukaryotic cell cycle by MAP kinase signaling pathways.FASEB J. 2000;14:2147\u20132157.","journal-title":"FASEB J."},{"key":"BF02982645_CR14","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/sj.leu.2402367","volume":"16","author":"SP Srinivasa","year":"2002","unstructured":"Srinivasa SP, Doshi PD. Extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways cooperate in mediating cytokine-induced proliferation of a leukemic cell line.Leukemia. 2002;16:244\u2013253.","journal-title":"Leukemia."},{"key":"BF02982645_CR15","doi-asserted-by":"publisher","first-page":"4601","DOI":"10.1038\/sj.onc.1205678","volume":"21","author":"M Korus","year":"2002","unstructured":"Korus M, Mahon GM, Cheng L, Whitehead IP. p38 MAPK mediated activation of NK-\u03baB by the RhoGEF domain of Bcr.Oncogene. 2002;21:4601\u20134612.","journal-title":"Oncogene."},{"key":"BF02982645_CR16","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1038\/sj.onc.1205150","volume":"21","author":"JA Recio","year":"2002","unstructured":"Recio JA, Merlino G. Hepatocyte growth factor\/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1.Oncogene. 2002;21:1000\u20131008.","journal-title":"Oncogene."},{"key":"BF02982645_CR17","doi-asserted-by":"publisher","first-page":"3860","DOI":"10.4049\/jimmunol.165.7.3860","volume":"165","author":"S Andjelic","year":"2000","unstructured":"Andjelic S, Hsia C, Suzuki H, Kadowaki T, Koyasu S, Liou H-C. Phosphatidylinositol 3-kinase and NF-\u03baB\/Rel are at the divergence of CD40-mediated proliferation and survival pathways.J Immunol. 2000;165:3860\u20133867.","journal-title":"J Immunol."},{"key":"BF02982645_CR18","first-page":"6763","volume":"60","author":"Y Tu","year":"2000","unstructured":"Tu Y, Gardner A, Lichtenstein A. The phosphatidylinositol 3-kinase\/ AKT kinase pathway in multiple myeloma plasma cells: roles in cytokine-dependent survival and proliferative responses.Cancer Res. 2000;60:6763\u20136770.","journal-title":"Cancer Res."}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02982645\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02982645.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02982645","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02982645.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,19]],"date-time":"2020-01-19T03:03:40Z","timestamp":1579403020000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02982645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,5]]}},"alternative-id":["BF02982645"],"URL":"https:\/\/doi.org\/10.1007\/bf02982645","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,5]]}}}